The treatment of diabetes mellitus of patients with chronic liver disease
Journal Title: Annals of Hepatology - Year 2015, Vol 14, Issue 6
Abstract
About 80% of patients with liver cirrhosis may have glucose metabolism disorders, 30% show overt diabetes mellitus (DM). Prospective studies have demonstrated that DM is associated with an increased risk of hepatic complications and death in patients with liver cirrhosis. DM might contribute to liver damage by promoting inflammation and fibrosis through an increase in mitochondrial oxidative stress mediated by adipokines. Based on the above mentioned the effective control of hyperglycemia may have a favorable impact on the evolution of these patients. However, only few therapeutic studies have evaluated the effectiveness and safety of antidiabetic drugs and the impact of the treatment of DM on morbidity and mortality in patients with liver cirrhosis. In addition, oral hypoglycemic agents and insulin may produce hypoglycemia and lactic acidosis, as most of these agents are metabolized by the liver. This review discusses the clinical implications of DM in patients with chronic liver disease. In addition the effectiveness and safety of old, but particularly the new antidiabetic drugs will be described based on pharmacokinetic studies and chronic administration to patients. Recent reports regarding the use of the SGLT2 inhibitors as well as the new incretin-based therapies such as injectable glucagon-like peptide-1 (GLP-1) receptor agonists and oral inhibitors of dipeptidylpeptidase-4 (DPP-4) will be discussed. The establishment of clear guidelines for the management of diabetes in patients with CLD is strongly required.
Authors and Affiliations
Diego García-Compeán, José González-González, Fernando Lavalle-González, Emmanuel González-Moreno, Héctor Maldonado-Garza, Jesús Villarreal-Pérez
Keywords
Related Articles
- EP ID EP78508
- DOI 10.5604/16652681.1171746
- Views 105
- Downloads 0
Abnormal liver function tests in a patient with myotonic dystrophy type 1
Myotonic dystrophy type 1, also known as Steinert’s disease, is a multisystemic disorder with significant genetic and clinical heterogeneity. Apart from skeletal muscles’ myotonia and wasting, a variety of system organs...
Extending a Helping Hand: Addressing Hepatitis C in Economic Migrants and Refugees
-
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C
Introduction. In patients with chronic hepatitis C it is still debated whether previous exposure to the hepatitis B virus, diagnosed from the presence of the anti-HBc antibody, is linked to a greater risk of severe hepat...
Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding
Administration of nonselective beta-blockers in prophylaxis of first variceal bleeding is not suitable for all patients. Thus, we evaluated endoscopic variceal band ligation (EVBL) in primary prevention of bleeding in pa...
Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage
Objective. Thyroid hormones profile in patients with hepatic cirrhosis due to chronic HBV and HCV infections was evaluated in order to find any relationship between thyroid hormones and severity of liver damage. Materia...